AstraZeneca shareholder 'delighted by board's resolve'

ITV News Business Editor spoke to AstraZeneca shareholder and fund manager Neil Woodford this evening, who said he was "delighted by the resolve of the board" and happy with their decision to reject the takeover bid.


My News at Ten live didn't happen. Had planned to set out detail of my chat with Neil Woodford - another fund manager staying loyal to AZ.


Woodford's stake in AstraZeneca "below 1%" but he was buying shares today. His bet: not on Pfizer's return "deal is dead" but AZ's future.


Value of Woodford's stake in AstraZeneca fell 11% today but he was "delighted by the resolve of the board, it was right to reject the bid".


Pfizer admits defeat on AstraZeneca bid

US pharmaceuticals giant Pfizer has called off its multi-billion pound bid to take over British-Swedish firm AstraZeneca. The decision came after AstraZeneca's board declined an offer worth almost £70bn.